The global adaptogen size was valued at USD 13.70 billion in 2024 and is projected to reach USD 23.19 billion by 2032, with a CAGR of 6.80% during the forecast period of 2025 to 2032.  The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions. One segment seeing tremendous traction...